Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1130029.RAhyR9Lm3DzERuzUeX6XtA1z43n3O1B34Bg30Kx8kEXQU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1130029.RAhyR9Lm3DzERuzUeX6XtA1z43n3O1B34Bg30Kx8kEXQU130_assertion type Assertion NP1130029.RAhyR9Lm3DzERuzUeX6XtA1z43n3O1B34Bg30Kx8kEXQU130_head.
- NP1130029.RAhyR9Lm3DzERuzUeX6XtA1z43n3O1B34Bg30Kx8kEXQU130_assertion description "[As sequencing technologies have become more sophisticated and have revealed an ever-increasing complexity of the genetic landscape of melanoma, it has become clear that sequencing methods applied to clinical specimens have to reliably capture not only recurrent hotspot mutations like BRAFV600 and NRASQ61 or mini-hotspot mutations like exon 11 and 13 c-KIT but also heterogeneous somatic mutations dispersed across multiple functionally conserved regions of genes or entire genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1130029.RAhyR9Lm3DzERuzUeX6XtA1z43n3O1B34Bg30Kx8kEXQU130_provenance.
- NP1130029.RAhyR9Lm3DzERuzUeX6XtA1z43n3O1B34Bg30Kx8kEXQU130_assertion evidence source_evidence_literature NP1130029.RAhyR9Lm3DzERuzUeX6XtA1z43n3O1B34Bg30Kx8kEXQU130_provenance.
- NP1130029.RAhyR9Lm3DzERuzUeX6XtA1z43n3O1B34Bg30Kx8kEXQU130_assertion SIO_000772 24258993 NP1130029.RAhyR9Lm3DzERuzUeX6XtA1z43n3O1B34Bg30Kx8kEXQU130_provenance.
- NP1130029.RAhyR9Lm3DzERuzUeX6XtA1z43n3O1B34Bg30Kx8kEXQU130_assertion wasDerivedFrom befree-2016 NP1130029.RAhyR9Lm3DzERuzUeX6XtA1z43n3O1B34Bg30Kx8kEXQU130_provenance.
- NP1130029.RAhyR9Lm3DzERuzUeX6XtA1z43n3O1B34Bg30Kx8kEXQU130_assertion wasGeneratedBy ECO_0000203 NP1130029.RAhyR9Lm3DzERuzUeX6XtA1z43n3O1B34Bg30Kx8kEXQU130_provenance.